论文信息 - A Phase II Immunochemotherapy Study with Alemtuzumab, Fludarabine, Cyclophosphamide, and Doxorubicin (Campath-FCD) in Peripheral T-Cell Lymphomas. - 字舞流文

A Phase II Immunochemotherapy Study with Alemtuzumab, Fludarabine, Cyclophosphamide, and Doxorubicin (Campath-FCD) in Peripheral T-Cell Lymphomas.

M. Dreyling | M. Subklewe | G. Hess | S. Krause | E. Jäger | K. Weisel | M. Soekler | E. Weidmann | J. Kruse | Soo‐Zin Kim